Table 4.
Recently isolated clinical strains of Phytobacter spp. not yet published
| Country | City, state | Species | Number of isolates | Isolation period | Sample(s), (number of isolates) | MDR1-positive | MDR-negative |
|---|---|---|---|---|---|---|---|
| Switzerland | Zürich2 | P. diazotrophicus | 2 | 2013–2014 | Blood (2) | 0 | 2 |
| Sweden | Gothenburg, Kalmar, Uppsala | P. diazotrophicus | 5 | 2008–2020 | Urine (1), blood (2), CAPD-fluid (1), sputum (1) | NA1 | NA |
| Gothenburg | P. ursingii | 1 | 2015 | Blood (1) | NA | NA | |
| Brazil | Curitiba-PR, São Paulo-SP, Cuiabá-MT | P. diazotrophicus | 9 | 2016–2021 | Urine (1), blood (4), rectal swab (2), eye infection (1), tracheal aspirate (1) | 3 | 6 |
| Curitiba-PR, São Paulo-SP | P. ursingii | 5 | 2016–2020 | Urine (1), blood (2), catheter (1), rectal swab (1) | 1 | 4 | |
| Curitiba-PR | Novel species | 2 | 2020 | Blood (2) | 0 | 2 |
1Abbreviations: MDR, multidrug-resistant; NA: not analysed
2Source: Dr. Frank Imkamp University of Zürich, Institute of Medical Microbiology, Molecular Diagnostics group, Zürich, Switzerland